Literature DB >> 28409249

[Combining radiation plus temozolomide in glioblastoma patients older than 65 years of age].

Christoph Straube1,2, Stephanie E Combs3,4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28409249     DOI: 10.1007/s00066-017-1134-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

Review 1.  Optimal management of elderly patients with glioblastoma.

Authors:  Normand Laperriere; Michael Weller; Roger Stupp; James R Perry; Alba A Brandes; Wolfgang Wick; Martin J van den Bent
Journal:  Cancer Treat Rev       Date:  2012-06-19       Impact factor: 12.111

2.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Authors:  Jan C Buckner; Edward G Shaw; Stephanie L Pugh; Arnab Chakravarti; Mark R Gilbert; Geoffrey R Barger; Stephen Coons; Peter Ricci; Dennis Bullard; Paul D Brown; Keith Stelzer; David Brachman; John H Suh; Christopher J Schultz; Jean-Paul Bahary; Barbara J Fisher; Harold Kim; Albert D Murtha; Erica H Bell; Minhee Won; Minesh P Mehta; Walter J Curran
Journal:  N Engl J Med       Date:  2016-04-07       Impact factor: 91.245

3.  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Authors:  Annika Malmström; Bjørn Henning Grønberg; Christine Marosi; Roger Stupp; Didier Frappaz; Henrik Schultz; Ufuk Abacioglu; Björn Tavelin; Benoit Lhermitte; Monika E Hegi; Johan Rosell; Roger Henriksson
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

4.  Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.

Authors:  James R Perry; Normand Laperriere; Christopher J O'Callaghan; Alba A Brandes; Johan Menten; Claire Phillips; Michael Fay; Ryo Nishikawa; J Gregory Cairncross; Wilson Roa; David Osoba; John P Rossiter; Arjun Sahgal; Hal Hirte; Florence Laigle-Donadey; Enrico Franceschi; Olivier Chinot; Vassilis Golfinopoulos; Laura Fariselli; Antje Wick; Loic Feuvret; Michael Back; Michael Tills; Chad Winch; Brigitta G Baumert; Wolfgang Wick; Keyue Ding; Warren P Mason
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

5.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

Authors:  W Roa; P M A Brasher; G Bauman; M Anthes; E Bruera; A Chan; B Fisher; D Fulton; S Gulavita; C Hao; S Husain; A Murtha; K Petruk; D Stewart; P Tai; R Urtasun; J G Cairncross; P Forsyth
Journal:  J Clin Oncol       Date:  2004-03-29       Impact factor: 44.544

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

7.  Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.

Authors:  Stephanie E Combs; Johanna Wagner; Marc Bischof; Thomas Welzel; Florian Wagner; Jürgen Debus; Daniela Schulz-Ertner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

8.  Radiotherapy for glioblastoma in the elderly.

Authors:  Florence Keime-Guibert; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Marc Frenay; Guy Kantor; Jean-Sébastien Guillamo; Eric Jadaud; Philippe Colin; Pierre-Yves Bondiau; Philippe Meneï; Hugues Loiseau; Valérie Bernier; Jérôme Honnorat; Maryline Barrié; Karima Mokhtari; Jean-Jacques Mazeron; Anne Bissery; Jean-Yves Delattre
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

9.  Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?

Authors:  Stephanie E Combs; Stefan Rieken; Wolfgang Wick; Amir Abdollahi; Andreas von Deimling; Jürgen Debus; Christian Hartmann
Journal:  Radiat Oncol       Date:  2011-09-13       Impact factor: 3.481

Review 10.  Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.

Authors:  Timothy J Brown; Matthew C Brennan; Michael Li; Ephraim W Church; Nicholas J Brandmeir; Kevin L Rakszawski; Akshal S Patel; Elias B Rizk; Dima Suki; Raymond Sawaya; Michael Glantz
Journal:  JAMA Oncol       Date:  2016-11-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.